Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Net Income

Arena Pharmaceutical Net Income Chart (ARNA)

Arena Pharmaceutical annual/quarterly Net Income from 2000 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Arena Pharmaceutical Net Income for the quarter ending December 12, 2018 was $69m a 146.52% increase of 101m year over year
  • Arena Pharmaceutical Net Income for the last 12 months ending December 12, 2018 was $-29m a -244.63% increase of 72m year over year
  • Arena Pharmaceutical Annual Net Income for 2018 was $-29m a -210.92% increase of 62m from 2017
  • Arena Pharmaceutical Annual Net Income for 2017 was $-91m a 75.37% decrease of -69m from 2016
  • Arena Pharmaceutical Annual Net Income for 2016 was $-23m a -379.57% increase of 85m from 2015
Other Income Statement Metrics:
  • Arena Pharmaceutical EBITDA for the quarter ending December 12, 2018 was $-44m a 31.55% decrease of -14m year over year
  • Arena Pharmaceutical Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Net Income Data

12/2018$69m
09/2018$-34m
06/2018$-32m
03/2018$-32m
12/2017$-14m
09/2017$-32m
06/2017$-23m
03/2017$-22m
09/2016$-12m
06/2016$-27m

Annual ARNA Net Income Data

2018$-29m
2017$-91m
2016$-23m
2015$-108m
2014$-61m
2013$-19m
2012$-85m
2011$-109m
2010$-125m
2009$-153m